TrialBMC medical genomics2026

Long-term safety and efficacy of triheptanoin in Korean patients with long-chain fatty acid oxidation disorders: a prospective, open-label, single-center, phase II clinical study.

Ji-Hee Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.